DSAEK continues to serve a purpose in corneal transplantation
Many complex cases are better suited to UT-DSAEK
Dermot McGrath
Published: Saturday, September 14, 2019
[caption id="attachment_16513" align="alignleft" width="1024"]
Massimo Busin[/caption]
ALTHOUGH corneal transplantation surgery has seen an increase in Descemet Membrane Endothelial Keratoplasty (DMEK) in recent years for the reported benefits of quicker healing and better visual outcomes, procedures such as ultrathin Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK) still have a valuable role to play for certain indications, according to Massimo Busin MD.
“DMEK is certainly a viable option for indications such as Fuchs’ endothelial dystrophy and gives excellent results, but there are still many complex cases, with poor visibility and certain comorbidities for instance, that are better suited to UT-DSAEK,” he told delegates attending the 10th EuCornea Congress in Paris.
Issues to bear in mind when considering UT-DSAEK versus DMEK is the preoperative eye status, surgical technique, outcomes and complications, noted Dr Busin. In his view, both procedures have a role to play depending on the needs of each individual patient.
DMEK is a good option, for instance in patients with Fuchs’ endothelial dystrophy, intact posterior capsule and normal anterior segment anatomy. However, UT-DSAEK is better adapted to cases with a shallow or poorly visualised anterior chamber or more complex eyes with ocular comorbidities such as glaucoma or severe pseudophakic bullous keratopathy, and aphakic or vitrectomised eyes.
Massimo Busin[/caption]
ALTHOUGH corneal transplantation surgery has seen an increase in Descemet Membrane Endothelial Keratoplasty (DMEK) in recent years for the reported benefits of quicker healing and better visual outcomes, procedures such as ultrathin Descemet Stripping Automated Endothelial Keratoplasty (UT-DSAEK) still have a valuable role to play for certain indications, according to Massimo Busin MD.
“DMEK is certainly a viable option for indications such as Fuchs’ endothelial dystrophy and gives excellent results, but there are still many complex cases, with poor visibility and certain comorbidities for instance, that are better suited to UT-DSAEK,” he told delegates attending the 10th EuCornea Congress in Paris.
Issues to bear in mind when considering UT-DSAEK versus DMEK is the preoperative eye status, surgical technique, outcomes and complications, noted Dr Busin. In his view, both procedures have a role to play depending on the needs of each individual patient.
DMEK is a good option, for instance in patients with Fuchs’ endothelial dystrophy, intact posterior capsule and normal anterior segment anatomy. However, UT-DSAEK is better adapted to cases with a shallow or poorly visualised anterior chamber or more complex eyes with ocular comorbidities such as glaucoma or severe pseudophakic bullous keratopathy, and aphakic or vitrectomised eyes.
Tags: dmek, Ultrathin DSAEK
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Picture This: Photo Contest Winners
ESCRS 2025 Refractive and Cataract Photo Contest winners.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.